iTreat Asthma

  • Study Sponsor and Protocol Number: 
    iTreat Primary Care - iTreat 23-10-462
  • Specialty:
    Pulmonology/Primary Care
  • Type:
    Investigational Medication - Azithromycin for Asthma
  • Inclusion:
    Age 13 - 75
    Current treatment with any dose of ICS inhaler
    One asthma flare up in the last 12 months
  • Exclusion:
    Allergy to azithromycin
    • Currently on R-ICS therapy (ex. AirSupra with another high dose inhaler)
    Known prolonged QT syndrome (can be tested at screening visit)